This ground-breaking study investigates whether existing, approved medications can be repurposed to treat vascular dementia—a prevalent yet under-researched form of dementia. By including patient groups often excluded from clinical trials, the team aims to address critical gaps in medical knowledge and accelerate the development of effective treatments.
Learn more about this vital research and its potential impact.
